Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News | Coronavirus (COVID-19)

September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...

Home September 08, 2020
Home
Abbott Espirit BTK Bioresorbable stent, or bioresorbable vascular scaffold (BVS) measures 99 microns and is made from poly-L-lactide (PLLA), a semi-crystalline bioresorbable polymer engineered to resist vessel recoil and provide a platform for drug delivery. Abbott Absorb
Feature | Stents Bioresorbable

September 3, 2020 — Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and ...

Home September 03, 2020
Home
News | Antiplatelet and Anticoagulation Therapies

September 2, 2020 — An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by ...

Home September 02, 2020
Home
News | ASE

August 20, 2020 – More than 350 posters featuring cutting edge research on the advances in cardiovascular ultrasound ...

Home August 20, 2020
Home
News | Heart Failure

 


August 17, 2020 — Pupil size predicts death and hospital readmission in patients with heart failure, according to r ...

Home August 17, 2020
Home
Videos | CT Angiography (CTA)

Todd Villines, M.D., FACC, FAHA, MSCCT, explains some of most influential cardiac CT clinical papers from the past year ...

Home August 11, 2020
Home
News | Atrial Fibrillation

August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF  investigational device exemption (IDE) ...

Home August 04, 2020
Home
News | Heart Failure

August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in ...

Home August 04, 2020
Home
News | Cardiogenic Shock

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart ...

Home August 03, 2020
Home
News | Pharmaceuticals

July 28, 2020 — AstraZeneca's heart failure medication dapagliflozin (Farxiga) significantly reduced the worsening of ...

Home July 28, 2020
Home
News | Stents

July 24, 2020 — CeloNova BioSciences Inc. announced it successfully completed enrollment of the COBRA REDUCE randomized ...

Home July 24, 2020
Home
Figure B — Top panel, neutrophils noted in collections within small vessels (blue arrow), plump endothelial cells (yellow arrowhead) and a single perivascular dying myocyte (blue arrowhead). Bottom panel, single myocyte undergoing degeneration (blue arrowhead) and plump endothelial cell (yellow arrowhead). Figure C — Electron microscopy, showing particles of SARS-CoV-2 virus present within a cardiac endothelial cell (blue arrowheads), but not present in neighboring cardiac myocyte. #COVID19
Feature | Coronavirus (COVID-19)

July 23, 2020 - A series of autopsies conducted by Louisiana State University (LSU) Health New Orleans pathologists ...

Home July 23, 2020
Home
News | Cardiovascular Clinical Studies

July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to ...

Home July 22, 2020
Home
News | ESC

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest ...

Home July 21, 2020
Home
Subscribe Now